 |
|
|
| |
High Rates Of HCV Reinfection And Retreatment In A Cohort Of PWID
With HCV Cure: Two Year Follow Up Data From The ANCHOR Study
|
| |
| |
AASLD 2020 Nov 11-16 virtual
Reported by Jules Levin
Sarah Kattakuzhy1,3, Julia Mount2,3, Christopher Brokus2, Rachel Cermak4, Alexandra Ritter4, Amelia Cover1,3, Ashley Davis1,3, Rahwa Eyasu1,3, Emade Ebah1,3, Rachel Silk1,3, Phyllis
Bijole5, Miriam Jones5, Randy Kier5, David Sternberg5, Shyam Kottilil1,3, Henry Masur2,3 and Elana Rosenthal1,3
(1)Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States, (2)Critical Care Medicine Department, Clinical Center, National Institutes of Health,
Bethesda, MD, United States, (3) DC Partnership for HIV/AIDS Progress, Washington, DC, United States, (4) University of Maryland School of Medicine, (5) HIPS, Org, Washington, DC, United States
Contact: Sarah Kattakuzhy, skattakuzhy@ihv.umaryland.edu
The ANCHOR study was supported by an investigator-initiated grant from Gilead Sciences paid to the institution (IHV/UMB)
|
| |
|
|
|
|
|
